Brevan Howard Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,800	Closed	-$47.8K	–	1796
2025 Q1	$47.8K	Buy	+14,800	New	+$47.8K	﹤0.01%	1045
2024 Q3	–	Sell	-11,079	Closed	-$233K	–	1181
2024 Q2	$233K	Buy	+11,079	New	+$233K	﹤0.01%	802